Active pharmaceutical ingredients are big business

被引:0
|
作者
Stoker, A [1 ]
机构
[1] Amec, Saskatoon, SK, Canada
来源
TCE | 2002年 / 732期
关键词
D O I
暂无
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
引用
收藏
页码:38 / 39
页数:2
相关论文
共 50 条
  • [1] Polymorphism of active pharmaceutical ingredients
    Karpinski, PH
    [J]. CHEMICAL ENGINEERING & TECHNOLOGY, 2006, 29 (02) : 233 - 237
  • [2] Prequalification of active pharmaceutical ingredients
    [J]. WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2015, 992 : 37 - 37
  • [3] Prequalification of active pharmaceutical ingredients
    [J]. WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2013, 981 : 29 - 29
  • [5] Manufacturing peptides as active pharmaceutical ingredients
    Zompra, Aikaterini A.
    Galanis, Athanassios S.
    Werbitzky, Oleg
    Albericio, Fernando
    [J]. FUTURE MEDICINAL CHEMISTRY, 2009, 1 (02) : 361 - 377
  • [6] The revival of cyclodextrins as active pharmaceutical ingredients
    Kfoury, Miriana
    Lichtfouse, Eric
    Fourmentin, Sophie
    [J]. ENVIRONMENTAL CHEMISTRY LETTERS, 2024,
  • [7] Ionic Liquids as Active Pharmaceutical Ingredients
    Ferraz, Ricardo
    Branco, Luis C.
    Prudencio, Cristina
    Noronha, Joao Paulo
    Petrovski, Zeljko
    [J]. CHEMMEDCHEM, 2011, 6 (06) : 975 - 985
  • [8] Precision active pharmaceutical ingredients are the goal
    Miller, Andrew D.
    [J]. FUTURE MEDICINAL CHEMISTRY, 2016, 8 (11) : 1209 - 1238
  • [9] RAMAN ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
    Mattley, Yvette
    [J]. CHEMICAL & ENGINEERING NEWS, 2014, : 31 - 31
  • [10] Active pharmaceutical ingredients and osteonecrosis of the jaw
    Orvosi Osztaly
    [J]. ORVOSI HETILAP, 2020, 161 (51) : 2176 - 2176